BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15767449)

  • 1. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
    Peng R; Moses SC; Tan J; Kremmer E; Ling PD
    J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
    Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
    Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBNA2 and Its Coactivator EBNA-LP.
    Kempkes B; Ling PD
    Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
    Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE
    PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function.
    McCann EM; Kelly GL; Rickinson AB; Bell AI
    J Gen Virol; 2001 Dec; 82(Pt 12):3067-3079. PubMed ID: 11714985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
    Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
    J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.
    Ling PD; Peng RS; Nakajima A; Yu JH; Tan J; Moses SM; Yang WH; Zhao B; Kieff E; Bloch KD; Bloch DB
    EMBO J; 2005 Oct; 24(20):3565-75. PubMed ID: 16177824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.
    Peng R; Gordadze AV; Fuentes Pananá EM; Wang F; Zong J; Hayward GS; Tan J; Ling PD
    J Virol; 2000 Jan; 74(1):379-89. PubMed ID: 10590127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
    Lin J; Johannsen E; Robertson E; Kieff E
    J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus.
    Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
    Portal D; Zhao B; Calderwood MA; Sommermann T; Johannsen E; Kieff E
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7808-13. PubMed ID: 21518914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
    Peng R; Tan J; Ling PD
    J Virol; 2000 Nov; 74(21):9953-63. PubMed ID: 11024123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
    J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B; Sample CE
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
    Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
    J Virol; 2018 May; 92(9):. PubMed ID: 29467311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.